Colon Cancer News
Overview: Top Research Published in 2012
A new article in Nature gave a quick overview of some of the top research published in 2012 from long-term follow-up of clinical trials.
- Showed that aspirin can be effective in the primary prevention of colon cancer in individuals with Lynch syndrome, although the dose is yet to be determined.
- Confirmed the efficacy of neoadjuvant chemoradiation (chemoradiation prior to surgery) in the treatment of rectal cancer
- Examined the benefits of the chemotherapy drug oxaliplatin in patients with colon cancer, and found that there was not a survival benefit in low risk stage II patients and the elderly.
- For patients that have metastatic disease, it safe to have chemo without having had surgery to remove an asymptomatic, not obstructing etc., primary colon or rectal tumor.
- Demonstrated the continued efficacy of the biologic drug bevacizumab after progression.
- Included the introduction of two new FDA-approved drugs, afilbercept and regorafenib.
Want to learn more about what’s coming up in colorectal cancer research? Register now for our free webinar, Colorectal Cancer: What’s New and What’s on the Horizon, on June 19, 2013 at 8 pm ET.
A review of Revisiting Landmark trials and identifying new therapies, by Christina Wu and Richard Goldberg. Nature. January 2013.